Bing

SEARCH HISTORY

Rexhan Pharmaceuticle Inc (NYSEMKT:RNN)’s stock price surged by 62.86% in Friday’s trading session. Apparently, the decision to stay focused solely on oncology Niche was the biggest catalyst for this rise. There is great prospect for this …
Live Trading News · 1/11/2014
The nearby chart of GNBT tells the story. After nearly four months' worth of a low, grinding drift lower, something lit a fire under the stock last Thursday, sending shares up above all of its short-term and intermediate-term moving averages. In fact ...
Smallcap Network · ByJames E. Brumley · 5/29/2013
and TORONTO, June 24, 2015 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that it entered ... non-voting Series G 9% Convertible Preferred Stock ("convertible preferred stock") and warrants to …
New Jersey Online · 6/24/2015
More from Bing News
On Friday, Generex (OTCQB:GNBT) Biotechnology announced that approval was given by shareholders to adjourn the Special Meeting until Monday to allow Generex to solicit additional proxies for a reverse stock split proposal. I have voted yes, and I would ...
Seeking Alpha · 10/16/2010
Looking at the technically chart, the stock closed at $.374 which is 11% higher than Tuesday’s closing price of $.332. GNBT has a 52-week high of $1.01 and a 52-week low of $.31. The momentum indicators are attempting to turn up from oversold levels …
Wall Street Pit · 7/28/2010
Generex Biotechnology Corporation (Nasdaq: GNBT) today announced its receipt of a decision by the NASDAQ Listing Qualifications Panel, which granted the Company's request for continued listing of the Company's common stock on The NASDAQ Stock
StreetInsider · 7/15/2010
GNBT ) shares fell 19% in trading Wednesday on news that the company will be delisted from the Nasdaq Capital Markets. So what: Generex first received a delisting notice in 2008 for having a stock price of less than $1.00. Since then, the company has ...
The Motley Fool · ByTravis Hoium · 10/20/2010
With the debate over the proposed reverse stock split still raging and their Phase III trial of Oral-lyn now several months behind schedule the future of Generex Biotechnology Corporation (OTCBB: GNBT) appears to be up in the air. While the biotechnology ...
OTC Equity · 11/10/2010
"GNBT recently announced that it has entered into a common stock purchase agreement with Seaside 88, LP, a private investment limited partnership. Seaside has committed to purchase up to 49,455,130 shares of GNBT common stock. Seaside will …
News-Medical · 4/19/2010
and TORONTO , May 4, 2015 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (GNBT ... news-releases/generex-announces-intention-to-dividend-a-portion-of-anticipated-smfi-securities-to-its-stockholders-upon-a-reverse-stock-split ...
Yahoo Finance · 5/4/2015